Aurobindo Pharma publishes notice on special window for physical share transfers

Compliance View source PDF Explain this filing

AUROPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+3.2%Reaction day

₹1645.00

prior close

₹1662.20

announcement price

In-mkt

timing

Nifty Midcap 150market+1.4%+1.8% vs market

Pharmaceuticals peers, median of 168sector-0.2%+3.4% vs sector

On the reaction day the stock moved 1.8 pts more than Nifty Midcap 150 and 3.4 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

-0.2

15m

-0.1

30m

-0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+3.2+1.4+1.8-0.2+3.4

Next day

+3.8+1.4+2.3-0.3+4.1

+2.4+2.4+0.0-0.4+2.8

+1.1+2.4-1.3-0.7+1.8

+2.0+2.1-0.1-1.2+3.2

+1.3+2.0-0.7-1.0+2.3

-4.0-0.5-3.5-4.2+0.2

15d

—————

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 168Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Aurobindo Pharma published a newspaper notice on October 9, 2026 about a SEBI special window from Feb 5, 2026 to Feb 4, 2027. This allows re-lodgement or fresh lodgement of physical share transfer requests for shares bought or sold before April 1, 2019. Transferred shares will be credited in demat form only with a one-year lock-in. Exclusions apply for disputes, IEPF shares, and missing certificates. RTA is MUFG Intime India.

Likely market impact

Routine compliance filing. Shareholders with pre-2019 physical share transfers should act before Feb 4, 2027. No material impact on stock price.